Stay updated with the latest fintech market trends, insights, and analysis. Explore breaking news, market movements, and expert opinions to make informed decisions in the ever-evolving financial technology landscape
US future markets drop after record highs; Fed minutes suggest pause in rate cuts
Published on: February 20, 2025, 05:01 AM UTC
Survey shows most US manufacturers in Vietnam would lay off workers if Trump imposes tariffs on exports.
Published on: February 20, 2025, 05:00 AM UTC
Palantir stock (PLTR) has slumped by 10% on news of the Trump administration planning budget cuts for the Pentagon. The cuts could affect Palantir, which makes AI software for surveillance used by the US government.
Published on: February 20, 2025, 04:01 AM UTC
US future markets fall after the S&P 500 reached a record high for the second time in a row, and investors digested the latest sign the Federal Reserve is unlikely to cut rates anytime soon.
Published on: February 20, 2025, 04:01 AM UTC
Canada's Trade Minister warns that Trump's tariffs will increase costs for Americans and vows to retaliate if necessary.
Published on: February 20, 2025, 04:01 AM UTC
Stocks sink in Asia as geopolitical tensions flare, S&P 500 futures drop. Yen strengthens, Treasuries rise, and gold holds near record high amid risk-off sentiment. Watch Alibaba earnings and key economic data this week.
Published on: February 20, 2025, 04:01 AM UTC
Asian shares fall on US-China trade jitters; S&P 500 sets record on Microsoft, Tesla boost
Published on: February 20, 2025, 04:00 AM UTC
Carvana shares dropped 10% in extended trading despite the company's better-than-expected earnings. Technical analysis identifies support levels at $235, $210, and $175, and a resistance area around $375 as the stock trades within an ascending channel.
Published on: February 20, 2025, 04:00 AM UTC
Atlanta Fed President Raphael Bostic says interest rate cuts are still possible this year as policymakers assess the economy and new Trump administration policies.
Published on: February 20, 2025, 03:01 AM UTC
The pharmaceutical industry and pharmacy benefit managers (PBMs) are at odds in Washington, D.C., as drug companies push for policies that would benefit patients at the expense of PBM profits. PBMs, such as CVS Caremark, defend their value in the healthcare system, while scrutiny from policymakers intensifies and new models for low-cost prescription access emerge.
Published on: February 20, 2025, 03:01 AM UTC